The retina-brain axis and diabetic retinopathy

被引:2
作者
Ebrahimi, Moein [1 ,2 ]
Thompson, Paul [3 ]
Lauer, Andreas K. [4 ]
Sivaprasad, Sobha [5 ,7 ]
Perry, George [6 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran
[2] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun, Tehran, Iran
[3] Univ Southern Calif, Mark & Mary Stevens Inst Neuroimaging & Informat, Imaging Genet Ctr, Keck Sch Med, Los Angeles, CA USA
[4] Oregon Hlth & Sci Univ, Casey Eye Inst, Dept Ophthalmol, Portland, OR USA
[5] Moorfields Eye Hosp, Natl Inst Hlth & Care Res, Moorfields Biomed Res Ctr, London, England
[6] Univ Texas & San Antonio, Dept Neurosci Dev & Regenerat Biol, San Antonio, TX USA
[7] Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England
关键词
Retina; optic nerve; Parkinson's disease; visual cortex; Alzheimer's disease; RETROGRADE AXONAL-TRANSPORT; LOW-FREQUENCY FLUCTUATION; PARKINSONS-DISEASE; OXIDATIVE STRESS; OPTIC-NERVE; TAU-HYPERPHOSPHORYLATION; PHOTORECEPTOR CELLS; NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; GANGLION-CELLS;
D O I
10.1177/11206721231172229
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Diabetic retinopathy (DR) is a major contributor to permanent vision loss and blindness. Changes in retinal neurons, glia, and microvasculature have been the focus of intensive study in the quest to better understand DR. However, the impact of diabetes on the rest of the visual system has received less attention. There are reports of associations of changes in the visual system with preclinical and clinical manifestations of diabetes. Simultaneous investigation of the retina and the brain may shed light on the mechanisms underlying neurodegeneration in diabetics. Additionally, investigating the links between DR and other neurodegenerative disorders of the brain including Alzheimer's and Parkinson's disease may reveal shared mechanisms for neurodegeneration and potential therapy options.
引用
收藏
页码:2079 / 2095
页数:17
相关论文
共 205 条
  • [1] Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat
    Abdouh, M
    Khanjari, A
    Abdelazziz, N
    Ongali, B
    Couture, R
    Hasséssian, HM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (01) : 33 - 40
  • [2] Occipital blood-brain barrier permeability is an independent predictor of visual outcome in type 2 diabetes, irrespective of the retinal barrier: A longitudinal study
    Abuhaiba, S. I.
    Cordeiro, M.
    Amorim, A.
    Cruz, A.
    Quendera, B.
    Ferreira, C.
    Ribeiro, L.
    Bernardes, R.
    Castelo-Branco, M.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2018, 30 (01)
  • [3] Diabetes and Hypercholesterolemia Increase Blood-Brain Barrier Permeability and Brain Amyloid Deposition: Beneficial Effects of the LpPLA2 Inhibitor Darapladib
    Acharya, Nimish K.
    Levin, Eli C.
    Clifford, Peter M.
    Han, Min
    Tourtellotte, Ryan
    Chamberlain, Dean
    Pollaro, Michael
    Coretti, Nicholas J.
    Kosciuk, Mary C.
    Nagele, Eric P.
    DeMarshall, Cassandra
    Freeman, Theresa
    Shi, Yi
    Guan, Chenbing
    Macphee, Colin H.
    Wilensky, Robert L.
    Nagele, Robert G.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (01) : 179 - 198
  • [4] Diabetic Retinopathy and BDNF: A Review on Its Molecular Basis and Clinical Applications
    Afarid, Mehrdad
    Namvar, Ehsan
    Sanie-Jahromi, Fatemeh
    [J]. JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [5] Local synchronization and amplitude of the fluctuation of spontaneous brain activity in attention-deficit/hyperactivity disorder: a resting-state fMRI study
    An, Li
    Cao, Qing-Jiu
    Sui, Man-Qiu
    Sun, Li
    Zou, Qi-Hong
    Zang, Yu-Feng
    Wang, Yu-Feng
    [J]. NEUROSCIENCE BULLETIN, 2013, 29 (05) : 603 - 613
  • [6] Current understanding of the molecular and cellular pathology of diabetic retinopathy
    Antonetti, David A.
    Silva, Paolo S.
    Stitt, Alan W.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (04) : 195 - 206
  • [7] Involvement of the Bradykinin B1 Receptor in Microglial Activation: In Vitro and In Vivo Studies
    Asraf, Keren
    Torika, Nofar
    Danon, Abraham
    Fleisher-Berkovich, Sigal
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [8] Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects
    Atlasz, T.
    Szabadfi, K.
    Kiss, P.
    Racz, B.
    Gallyas, F.
    Tamas, A.
    Gaal, V.
    Marton, Zs.
    Gabriel, R.
    Reglodi, D.
    [J]. PHYLOGENETIC ASPECTS OF NEUROPEPTIDES: FROM INVERTEBRATES TO HUMANS, 2010, 1200 : 128 - 139
  • [9] Dopamine Deficiency Contributes to Early Visual Dysfunction in a Rodent Model of Type 1 Diabetes
    Aung, Moe H.
    Park, Han Na
    Han, Moon K.
    Obertone, Tracy S.
    Abey, Jane
    Aseem, Fazila
    Thule, Peter M.
    Iuvone, P. Michael
    Pardue, Machelle T.
    [J]. JOURNAL OF NEUROSCIENCE, 2014, 34 (03) : 726 - 736
  • [10] Exenatide and the treatment of patients with Parkinson's disease
    Aviles-Olmos, Iciar
    Dickson, John
    Kefalopoulou, Zinovia
    Djamshidian, Atbin
    Ell, Peter
    Soderlund, Therese
    Whitton, Peter
    Wyse, Richard
    Isaacs, Tom
    Lees, Andrew
    Limousin, Patricia
    Foltynie, Thomas
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06) : 2730 - 2736